Superselective vesical artery embolization versus intravesical formalin for intractable hematuria in patients with bladder cancer

CONCLUSION: The advantages of IF appear to include shorter postoperative hospital stays and higher success rates at a single session, while the advantages of SVAE seem to include non-requirement of spinal/general anesthesia, easy repeatability, and low complication rates. In the management of patients with intractable hematuria, patients' general condition, comorbidities, and anesthesia-related risks should be taken into consideration.PMID:34332813 | DOI:10.1016/j.acuro.2020.11.009
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Authors: Source Type: research

Related Links:

CONCLUSIONS: Older age was not associated with an increased risk of major complications in patients who undergo radical cystectomy because of MIBC. Therefore, older age alone should not be a contraindication to this operation.PMID:34950268 | PMC:PMC8669987 | DOI:10.5114/wiitm.2021.103918
Source: Videosurgery and Other Miniinvasive Techniques - Category: Surgery Authors: Source Type: research
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson &Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease wh...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Urol Oncol. 2020 Oct 23:S1078-1439(20)30477-4. doi: 10.1016/j.urolonc.2020.10.004. Online ahead of print.ABSTRACTNon-muscle-invasive bladder cancer is one of the most common malignancies. Patients with intermediate-risk or high-risk disease can be treated with intravesical Bacillus Calmette-Guerin, a vaccine against tuberculosis. However, many of these patients will experience tumor recurrence, despite appropriate treatment. 1 The standard of care in these patients is radical cystectomy (RC) with urinary diversion. 2 Patients diagnosed with muscle-invasive bladder cancer (MIBC) have traditionally faced 2 main treatment opt...
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Source Type: research
More News: Anesthesia | Anesthesiology | Bladder Cancer | Cancer | Cancer & Oncology | Study | Urology & Nephrology